ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.745,04
-0,01%
Dow Jones
42.426,46
0,60%
Euro vs US Dollar
1,11524
-0,21%
Bitcoin
66.228,50
1,60%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Organigram Holdings Inc (OGI)

  7. Organigram Holdings Inc (OGI) News

OGI

Organigram (OGI)

Organigram Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OGI
DatumZeitQuelleÜberschriftSymbolFirma
03/09/202415h30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OGIOrganigram Holdings Inc
03/09/202415h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
03/09/202412h00Business WireOrganigram Closes Second Tranche of Previously Announced BAT Private Placement InvestmentNASDAQ:OGIOrganigram Holdings Inc
13/08/202413h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
13/08/202412h30Business WireOrganigram Reports Third Quarter Fiscal 2024 ResultsNASDAQ:OGIOrganigram Holdings Inc
07/08/202417h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
07/08/202412h00Business WireOrganigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion TechnologyNASDAQ:OGIOrganigram Holdings Inc
06/08/202416h32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
06/08/202412h00Business WireOrganigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024NASDAQ:OGIOrganigram Holdings Inc
29/07/202417h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
29/07/202412h00Business WireOrganigram Announces Appointment of Craig Harris to Board of DirectorsNASDAQ:OGIOrganigram Holdings Inc
24/07/202423h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
24/07/202412h00Business WireOrganigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into PhylosNASDAQ:OGIOrganigram Holdings Inc
12/07/202421h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
26/06/202415h15Business WireOrganigram investe in Sanity Group, società leader tedesca nel settore della cannabisNASDAQ:OGIOrganigram Holdings Inc
26/06/202415h15Business WireOrganigram investiert in Sanity Group, ein führendes deutsches CannabisunternehmenNASDAQ:OGIOrganigram Holdings Inc
26/06/202415h15Business WireOrganigram investit dans Sanity Group, un chef de file du cannabis en AllemagneNASDAQ:OGIOrganigram Holdings Inc
25/06/202414h00Business WireOrganigram Invests in Sanity Group, a Leading German Cannabis CompanyNASDAQ:OGIOrganigram Holdings Inc
28/05/202415h38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
28/05/202412h00Business WireOrganigram Signs Three Year Supply Agreement with Avida Medical in UKNASDAQ:OGIOrganigram Holdings Inc
14/05/202413h18IH Market NewsUS Futures Remain Steady Amid Wall Street Caution Ahead of April PPI ReportNASDAQ:OGIOrganigram Holdings Inc
14/05/202413h17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
14/05/202412h00Business WireOrganigram Reports Second Quarter Fiscal 2024 ResultsNASDAQ:OGIOrganigram Holdings Inc
08/05/202417h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OGIOrganigram Holdings Inc
08/05/202414h00Business WireOrganigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024NASDAQ:OGIOrganigram Holdings Inc
08/04/202412h00Business WireOrganigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive YearNASDAQ:OGIOrganigram Holdings Inc
03/04/202414h06Business WireOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesNASDAQ:OGIOrganigram Holdings Inc
02/04/202414h51Business WireOrganigram Successfully Closes Previously Announced Underwritten Public OfferingNASDAQ:OGIOrganigram Holdings Inc
27/03/202413h56Business WireOrganigram Announces Pricing of Overnight Marketed Public OfferingNASDAQ:OGIOrganigram Holdings Inc
27/03/202400h06Business WireOrganigram Announces Launch of Overnight Marketed Public OfferingNASDAQ:OGIOrganigram Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:OGI

Kürzlich von Ihnen besucht

LSE
46TB
Qnb Fin 23
TG
AMC
Albemarle
NASDAQ
AAWPBXX
Morgan Stanley Bank Na P...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten